90 related articles for article (PubMed ID: 12186341)
1. Tibolone, blood pressure and obesity.
Roshan J; Ganesh A
Natl Med J India; 2002; 15(3):180. PubMed ID: 12186341
[No Abstract] [Full Text] [Related]
2. A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
Sundar SS; Gornall RJ; Kerr-Wilson R; Swingler GR; Kinder RB; McCarthy K
J Obstet Gynaecol; 2007 May; 27(4):433-4. PubMed ID: 17654209
[No Abstract] [Full Text] [Related]
3. Complex endometrial hyperplasia in the context of tibolone administration.
Kane SC; Quinn MA
Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):338-9. PubMed ID: 19566575
[No Abstract] [Full Text] [Related]
4. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
[TBL] [Abstract][Full Text] [Related]
5. The LIBERATE tibolone trial in breast cancer survivors.
Speroff L
Maturitas; 2009 May; 63(1):1-3. PubMed ID: 19327923
[No Abstract] [Full Text] [Related]
6. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
7. Tibolone.
Reynir Tomas G
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):606. PubMed ID: 15144349
[No Abstract] [Full Text] [Related]
8. Tibolone: the risk is too high.
Goodwin PJ
Lancet Oncol; 2009 Feb; 10(2):103-4. PubMed ID: 19185829
[No Abstract] [Full Text] [Related]
9. Effects of hormone replacement therapy on mammographic findings.
Bülbül NH; Ozden S; Dayicioglu V
Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
[TBL] [Abstract][Full Text] [Related]
11. Endometrial effects of tibolone in elderly, osteoporotic women.
Ettinger B; Kenemans P; Johnson SR; Mol-Arts M; Van Os S; Seifert W; Verweij PJ; Cummings SR
Obstet Gynecol; 2008 Sep; 112(3):653-9. PubMed ID: 18757665
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
[TBL] [Abstract][Full Text] [Related]
13. [Tibolone therapy in postmenopausal women with a history of many risk factors].
Szántó F
Orv Hetil; 2003 Apr; 144(15):701-4. PubMed ID: 12774429
[TBL] [Abstract][Full Text] [Related]
14. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
15. Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125.
Davies AP; Oram D
Br J Obstet Gynaecol; 1994 Jul; 101(7):632-3. PubMed ID: 8043545
[No Abstract] [Full Text] [Related]
16. Endometrial cancer--surprising reports.
Speroff L
Maturitas; 2005 Aug; 51(4):329-33. PubMed ID: 16039404
[No Abstract] [Full Text] [Related]
17. Hormone therapy and raloxifene reduce the coagulation inhibitor potential.
Andresen MS; Eilertsen AL; Abildgaard U; Sandset PM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):455-60. PubMed ID: 17581320
[TBL] [Abstract][Full Text] [Related]
18. Some comments on the Million Women Study.
Neves-E-Castro M
Climacteric; 2003 Dec; 6(4):357. PubMed ID: 15006258
[No Abstract] [Full Text] [Related]
19. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
20. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
Kenemans P; Speroff L;
Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]